Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.694 USD | -0.86% | +3.74% | +35.34% |
Mar. 28 | Atara Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 28 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q4 Revenue $4.3M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.34% | 71.35M | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |
- Stock
- Equities
- Stock Atara Biotherapeutics, Inc. - Nasdaq
- News Atara Biotherapeutics, Inc.
- Atara Biotherapeutics, Bayer Collaboration on CAR T-cell Therapies to be Terminated in September -- Shares Drop in Late Hours